![Daniel Karp](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Karp
Director/Board Member at
CARTESIAN GROWTH CORPORATION II
Net worth: 927 757 $ as of 2026-05-30
Profile
Daniel Karp is currently an Independent Director at Cartesian Growth Corp.
II since 2022 and Executive Vice President-Corporate Development at Organon & Co. Former positions include Independent Director at Cartesian Growth Corp., Vice President-Worldwide Business Development at Pfizer Inc. from 2016 to 2018, and Executive Vice President-Corporate Development at Biogen, Inc. from 2018 to 2020.
Education includes an undergraduate degree from Duke University and an MBA from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ORGANON & CO. 0.03% | 2026-03-30 | 69,547 ( 0.03% ) | 927 757 $ | 2026-05-30 |
Daniel Karp active positions
| Companies | Position | Start |
|---|---|---|
| CARTESIAN GROWTH CORPORATION II | Director/Board Member | 2022-04-30 |
| ORGANON & CO. | Corporate Officer/Principal | - |
Former positions of Daniel Karp
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 2020-04-30 |
| PFIZER INC. | Corporate Officer/Principal | 2018-05-31 |
| ALVARIUM TIEDEMANN A | Director/Board Member | - |
Training of Daniel Karp
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
80
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cartesian Growth Corp.
 Cartesian Growth Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Organon & Co.
 Organon & Co. Pharmaceuticals: MajorHealth Technology Develops and delivers women health, trusted legacy brands and therapeutics | Health Technology |
Cartesian Growth Corp. II
 Cartesian Growth Corp. II Financial ConglomeratesFinance Operates as a blank check company | Finance |
- Stock Market
- Insiders
- Daniel Karp
